F2 and COVID-19: Preliminary studies in Wuhan, China, showed that most patients with COVID-19 who died of disease had coagulation disorders, characterized by prolonged prothrombin time and partial prothrombin kinase time, similar to the characteristics observed in patients with disseminated intravascular coagulation (Zhou et al., 2020).